Trial Profile
Double-blind, placebo-controlled single and multiple rising dose study of brivaracetam in healthy Japanese male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- Sponsors UCB Pharma SA
- 08 Dec 2011 New trial record